SUBSCRIBE
SUBSCRIBE

Australia

Genetown
Why Scientists Should Ditch The Postdoc And Just Jump Into The Industry
July 26, 2017
 · 
1 min read
Genetown
How Scientists Can Negotiate Higher Salary Contracts
July 26, 2017
 · 
1 min read
This Biotech Aims To Transform The Diagnosis Of Mental Illness. Michael Phelps Backs It. Can It Really Work?
July 21, 2017
 · 
1 min read
Ansell Implements $100 Million Restructuring After Sale of Condom Biz
July 20, 2017
 · 
1 min read
Genetown
Why You Should Always Question the Hiring Manager During An Interview
July 19, 2017
 · 
1 min read
Genetown
5 Tips for Increasing Your Chance Of Being Headhunted
July 19, 2017
 · 
1 min read
Genetown
5 Key Elements Of A Resume That Will Make A Great First Impression
July 19, 2017
 · 
1 min read
Genetown
How A Scientist With A PhD Is An Advantage At A Job Interview
July 19, 2017
 · 
1 min read
Genetown
How To Advance Your Scientific Career By Working For A CRO
July 19, 2017
 · 
1 min read
Science May Just Have Found A Way To Treat The Flu And Common Cold, Nature Communications Reveals
July 13, 2017
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Amplia Therapeutics to Present at 2026 ASCO Gastrointestinal Cancers Symposium
December 24, 2025
 · 
2 min read
Press Releases
Kazia Therapeutics Regains Full Nasdaq Listing Compliance
December 23, 2025
 · 
3 min read
Press Releases
Immutep Announces Positive Update on IMP761, a First-in-Class LAG-3 Agonist Antibody for Autoimmune Diseases, from Phase I Study
December 23, 2025
 · 
5 min read
Press Releases
Propanc Biopharma Publishes Impact of Proenzymes on Pancreatic Ductal Adenocarcinoma Fibroblasts in Peer Reviewed Journal
December 23, 2025
 · 
4 min read
Press Releases
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions
December 22, 2025
 · 
11 min read
Press Releases
Final, 247th participant randomized and commences treatment in Actinogen’s XanaMIA pivotal phase 2b/3 Alzheimer’s trial
December 19, 2025
 · 
8 min read
Press Releases
Vir Biotechnology Grants Norgine Exclusive Commercial License to Chronic Hepatitis Delta Treatment Candidate in Europe, Australia & New Zealand, Including Global Cost Sharing Agreement for Ongoing ECLIPSE Clinical Development Program
December 17, 2025
 · 
9 min read
Press Releases
Immutep Announces Strong Operational Progress in Global TACTI-004 (KEYNOTE-F91) Phase III and Enrolment Continues at Robust Pace
December 17, 2025
 · 
4 min read
Press Releases
Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution
December 16, 2025
 · 
3 min read
Press Releases
Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases
December 15, 2025
 · 
5 min read
Press Releases
Patient Enrolment Completed in Phase 2 aGvHD Clinical Trial
December 15, 2025
 · 
4 min read
Press Releases
FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial
December 12, 2025
 · 
4 min read
Press Releases
Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase 3 Trial for Prader-Willi Syndrome
December 11, 2025
 · 
6 min read
Press Releases
Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib’s Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations including TNBC and HER2+
December 10, 2025
 · 
9 min read
Press Releases
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
December 10, 2025
 · 
13 min read
Press Releases
AdvanCell Receives First Delivery of High-Activity Thorium-228, Highlighting a Unique Industry Capability and Expertise Essential to Scaling Lead-212 Production for Targeted Alpha Therapies
December 9, 2025
 · 
4 min read
Press Releases
CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies
December 8, 2025
 · 
7 min read
Press Releases
Key Narmafotinib Patent Granted in the U.S.
December 4, 2025
 · 
2 min read
Press Releases
AdvanCell Initiates Phase 2 Expansion Trial of ADVC001, a Novel Targeted Alpha Therapy for Prostate Cancer
December 3, 2025
 · 
4 min read
Press Releases
CYIOS Corp. Appoints John O’Shea as Chief Executive Officer to Lead Next Phase of Growth and Innovation
December 3, 2025
 · 
5 min read
Load More